Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, Maj-Linda B., Brownlow, Milene, Jimenez, Jeffy P., Lee, Daniel C., Pena, Gabriela, Dickey, Chad A., Gordon, Marcia N., Morgan, Dave·2013·Neurodegenerative Diseases
DOI 10.1159/000337230

Cited by (1,606)

Items 1,001–1,100 of 1,606

  1. Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
    Lars Matthias Ittner, Thomas Fath, Yazi Diana Ke, Mian Bi, Janet van Eersel, Kong M. Li, Peter William Gunning, Jürgen Götz · 2008 · Proceedings of the National Academy of Sciences
  2. Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell Transplantation
    Dorothée Cantinieaux, Renaud Quertainmont, Silvia Blacher, Loïc Rossi, Thomas Wanet, Agnès Noël, Gary Anthony Brook, Jean E. Schoenen, Rachelle Franzen · 2013 · PLoS ONE
  3. Interleukin-1β impairs brain derived neurotrophic factor-induced signal transduction
    Tong, Liqi, Balazs, Robert, Soiampornkul, Rungtip, Thangnipon, Wipawan, Cotman, Carl W. · 2008 · Neurobiology of Aging
  4. Tau in neurodegenerative disease
    Gao, Yong-Lei, Wang, Nan, Sun, Fu-Rong, Cao, Xi-Peng, Zhang, Wei, Yu, Jin-Tai · 2018 · Annals of Translational Medicine
  5. Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice
    Caballero, Benjamin, Bourdenx, Mathieu, Luengo, Enrique, Diaz, Antonio, Sohn, Peter Dongmin, Chen, Xu, Wang, Chao, Juste, Yves R., Wegmann, Susanne, Patel, Bindi et al. · 2021 · Nature Communications
  6. β-Amyloid Peptide at Sublethal Concentrations Downregulates Brain-Derived Neurotrophic Factor Functions in Cultured Cortical Neurons
    Tong, Liqi, Balazs, Robert, Thornton, Phillip L., Cotman, Carl W. · 2004 · The Journal of Neuroscience
  7. Rodent models for Alzheimer’s disease drug discovery
    Puzzo, Daniela, Gulisano, Walter, Palmeri, Agostino, Arancio, Ottavio · 2015 · Expert Opinion on Drug Discovery
  8. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer’s disease
    Shao, Charles Y., Mirra, Suzanne S., Sait, Hameetha B. R., Sacktor, Todd C., Sigurdsson, Einar M. · 2011 · Acta Neuropathologica
  9. Early N-Terminal Changes and Caspase-6 Cleavage of Tau in Alzheimer's Disease
    Horowitz, Peleg M., Patterson, Kristina R., Guillozet-Bongaarts, Angela L., Reynolds, Matthew R., Carroll, Christopher A., Weintraub, Susan T., Bennett, David A., Cryns, Vincent L., Berry, Robert W., Binder, Lester I. · 2004 · The Journal of Neuroscience
  10. Anti-Alzheimer’s Studies on β-Sitosterol Isolated from Polygonum hydropiper L.
    Ayaz, Muhammad, Junaid, Muhammad, Ullah, Farhat, Subhan, Fazal, Sadiq, Abdul, Ali, Gowhar, Ovais, Muhammad, Shahid, Muhammad, Ahmad, Ashfaq, Wadood, Abdul et al. · 2017 · Frontiers in Pharmacology
  11. Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease
    Goetzl, Edward J., Abner, Erin L., Jicha, Gregory A., Kapogiannis, Dimitrios, Schwartz, Janice B. · 2018 · The FASEB Journal
  12. CSF biomarkers in frontotemporal lobar degeneration with known pathology
    Bian, H., Van Swieten, J. C., Leight, S., Massimo, L., Wood, E., Forman, M., Moore, P., de Koning, I., Clark, C. M., Rosso, S. et al. · 2008 · Neurology
  13. What happens to your brain on the way to Mars
    Parihar, Vipan K., Allen, Barrett, Tran, Katherine K., Macaraeg, Trisha G., Chu, Esther M., Kwok, Stephanie F., Chmielewski, Nicole N., Craver, Brianna M., Baulch, Janet E., Acharya, Munjal M. et al. · 2015 · Science Advances
  14. Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies
    Sinsky, Jakub, Pichlerova, Karoline, Hanes, Jozef · 2021 · International Journal of Molecular Sciences
  15. Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system
    Buckman, Laura B., Hasty, Alyssa H., Flaherty, David K., Buckman, Christopher T., Thompson, Misty M., Matlock, Brittany K., Weller, Kevin, Ellacott, Kate L.J. · 2014 · Brain Behavior and Immunity
  16. The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
    Andrade, Andreia G., Bubu, Omonigho M., Varga, Andrew W., Osorio, Ricardo S. · 2018 · Journal of Alzheimer's Disease
  17. Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
    Morris, Gary P., Clark, Ian A., Vissel, Bryce · 2018 · Acta Neuropathologica
  18. Gene–environment interactions in Alzheimer disease: the emerging role of epigenetics
    Migliore, Lucia, Coppedè, Fabio · 2022 · Nature Reviews Neurology
  19. Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
    Spiteri, Alanna G., Wishart, Claire L., Pamphlett, Roger, Locatelli, Giuseppe, King, Nicholas J. C. · 2022 · Acta Neuropathologica
  20. Intersection of pathological tau and microglia at the synapse
    Vogels, Thomas, Murgoci, Adriana-Natalia, Hromádka, Tomáš · 2019 · Acta Neuropathologica Communications
  21. CNS expression of anti‐inflammatory cytokine interleukin‐4 attenuates Alzheimer's disease‐like pathogenesis in APP+PS1 bigenic mice
    Kiyota, Tomomi, Okuyama, Satoshi, Swan, Russell J., Jacobsen, Michael T., Gendelman, Howard E., Ikezu, Tsuneya · 2010 · The FASEB Journal
  22. Activated microglia mitigate Aβ-associated tau seeding and spreading
    Gratuze, Maud, Chen, Yun, Parhizkar, Samira, Jain, Nimansha, Strickland, Michael R., Serrano, Javier Remolina, Colonna, Marco, Ulrich, Jason D., Holtzman, David M. · 2021 · Journal of Experimental Medicine
  23. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients
    Huell, Michael, Strauss, Sylvia, Volk, Benedikt, Berger, Mathias, Bauer, Joachim · 1995 · Acta Neuropathologica
  24. Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
    Kim, Do-Geun, Krenz, Antje, Toussaint, Leon E., Maurer, Kirk J., Robinson, Sudie-Ann, Yan, Angela, Torres, Luisa, Bynoe, Margaret S. · 2016 · Journal of Neuroinflammation
  25. Therapeutic B-cell depletion reverses progression of Alzheimer’s disease
    Kim, Ki, Wang, Xin, Ragonnaud, Emeline, Bodogai, Monica, Illouz, Tomer, DeLuca, Marisa, McDevitt, Ross A., Gusev, Fedor, Okun, Eitan, Rogaev, Evgeny et al. · 2021 · Nature Communications
  26. The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
    Jack, Clifford R, Wiste, Heather J, Botha, Hugo, Weigand, Stephen D, Therneau, Terry M, Knopman, David S, Graff-Radford, Jonathan, Jones, David T, Ferman, Tanis J, Boeve, Bradley F et al. · 2019 · Brain
  27. Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases
    Nakagawa, Yutaka, Chiba, Kenji · 2014 · Pharmaceuticals
  28. Spinal Microgliosis Due to Resident Microglial Proliferation Is Required for Pain Hypersensitivity after Peripheral Nerve Injury
    Gu, Nan, Peng, Jiyun, Murugan, Madhuvika, Wang, Xi, Eyo, Ukpong B., Sun, Dongming, Ren, Yi, DiCicco-Bloom, Emanuel, Young, Wise, Dong, Hailong et al. · 2016 · Cell Reports
  29. Amyloid-Associated Neuron Loss and Gliogenesis in the Neocortex of Amyloid Precursor Protein Transgenic Mice
    Bondolfi, Luca, Calhoun, Michael, Ermini, Florian, Kuhn, H. Georg, Wiederhold, Karl-Heinz, Walker, Lary, Staufenbiel, Matthias, Jucker, Mathias · 2002 · The Journal of Neuroscience
  30. Propagation of Tau aggregates
    Goedert, Michel, Spillantini, Maria Grazia · 2017 · Molecular Brain
  31. Mouse Models of Alzheimer’s Disease
    Yokoyama, Miyabishara, Kobayashi, Honoka, Tatsumi, Lisa, Tomita, Taisuke · 2022 · Frontiers in Molecular Neuroscience
  32. APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis
    Uddin, Md. Sahab, Kabir, Md. Tanvir, Al Mamun, Abdullah, Abdel-Daim, Mohamed M., Barreto, George E., Ashraf, Ghulam Md · 2019 · Molecular Neurobiology
  33. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer’s Disease
    Guo, Lan, Tian, Jing, Du, Heng · 2017 · Journal of Alzheimer’s Disease
  34. Cortical Synaptic Integration<i>In Vivo</i>Is Disrupted by Amyloid-β Plaques
    Stern, Edward A., Bacskai, Brian J., Hickey, Gregory A., Attenello, Frank J., Lombardo, Julianne A., Hyman, Bradley T. · 2004 · The Journal of Neuroscience
  35. Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease
    Oddo, Salvatore, Caccamo, Antonella, Green, Kim N., Liang, Kevin, Tran, Levina, Chen, Yiling, Leslie, Frances M., LaFerla, Frank M. · 2005 · Proceedings of the National Academy of Sciences
  36. Transgenic Mouse Model of Tau Pathology in Astrocytes Leading to Nervous System Degeneration
    Forman, Mark S., Lal, Devika, Zhang, Bin, Dabir, Deepa V., Swanson, Eric, Lee, Virginia M.-Y., Trojanowski, John Q. · 2005 · The Journal of Neuroscience
  37. Tau deletion promotes brain insulin resistance
    Marciniak, Elodie, Leboucher, Antoine, Caron, Emilie, Ahmed, Tariq, Tailleux, Anne, Dumont, Julie, Issad, Tarik, Gerhardt, Ellen, Pagesy, Patrick, Vileno, Margaux et al. · 2017 · Journal of Experimental Medicine
  38. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics
    Kim, Namhee, Yun, Misun, Oh, Young Joon, Choi, Hak-Jong · 2018 · Journal of Microbiology
  39. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer’s disease
    Wang, Hong, Dey, Kaushik Kumar, Chen, Ping-Chung, Li, Yuxin, Niu, Mingming, Cho, Ji-Hoon, Wang, Xusheng, Bai, Bing, Jiao, Yun, Chepyala, Surendhar Reddy et al. · 2020 · Molecular Neurodegeneration
  40. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
    Chang, Eric H., Savage, Mary J., Flood, Dorothy G., Thomas, Justin M., Levy, Robert B., Mahadomrongkul, Veeravan, Shirao, Tomoaki, Aoki, Chiye, Huerta, Patricio T. · 2006 · Proceedings of the National Academy of Sciences
  41. The Alzheimer's disease mitochondrial cascade hypothesis: an update
    Swerdlow, Russell H., Khan, Shaharyar M. · 2009 · Experimental Neurology
  42. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease
    Kirouac, Lisa, Rajic, Alexander J., Cribbs, David H., Padmanabhan, Jaya · 2017 · eneuro
  43. Altered Proteins in the Aging Brain
    Elobeid, Adila, Libard, Sylwia, Leino, Marina, Popova, Svetlana N., Alafuzoff, Irina · 2016 · Journal of Neuropathology &amp; Experimental Neurology
  44. Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
    Widman, Allie J., McMahon, Lori L. · 2018 · Proceedings of the National Academy of Sciences
  45. Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
    Regan, Philip, Piers, Thomas, Yi, Jee-Hyun, Kim, Dong-Hyun, Huh, Seonghoo, Park, Se Jin, Ryu, Jong Hoon, Whitcomb, Daniel J., Cho, Kwangwook · 2015 · The Journal of Neuroscience
  46. Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide
    Sharma, Anuj K., Pavlova, Stephanie T., Kim, Jaekwang, Finkelstein, Darren, Hawco, Nicholas J., Rath, Nigam P., Kim, Jungsu, Mirica, Liviu M. · 2012 · Journal of the American Chemical Society
  47. Drusen deposits associated with aging and age-related macular degeneration contain nonfibrillar amyloid oligomers
    Luibl, V. · 2006 · Journal of Clinical Investigation
  48. Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer’s Disease Dementia in a Large National Survey
    Beydoun, May A., Beydoun, Hind A., Hossain, Sharmin, El-Hajj, Ziad W., Weiss, Jordan, Zonderman, Alan B. · 2020 · Journal of Alzheimer's Disease
  49. <i>Porphyromonas gingivalis</i> Periodontal Infection and Its Putative Links with Alzheimer’s Disease
    Singhrao, Sim K., Harding, Alice, Poole, Sophie, Kesavalu, Lakshmyya, Crean, StJohn · 2015 · Mediators of Inflammation
  50. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography
    Sanchez, Justin S., Becker, J. Alex, Jacobs, Heidi I. L., Hanseeuw, Bernard J., Jiang, Shu, Schultz, Aaron P., Properzi, Michael J., Katz, Samantha R., Beiser, Alexa, Satizabal, Claudia L. et al. · 2021 · Science Translational Medicine
  51. Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent Proteins
    Klein, Ronald L., Dayton, Robert D., Leidenheimer, Nancy J., Jansen, Karen, Golde, Todd E., Zweig, Richard M. · 2006 · Molecular Therapy
  52. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
    Chen, Xianwei, Sun, Guoqiang, Tian, E, Zhang, Mingzi, Davtyan, Hayk, Beach, Thomas G., Reiman, Eric M., Blurton‐Jones, Mathew, Holtzman, David M., Shi, Yanhong · 2021 · Advanced Science
  53. Tau co-organizes dynamic microtubule and actin networks
    Elie, Auréliane, Prezel, Elea, Guérin, Christophe, Denarier, Eric, Ramirez-Rios, Sacnicte, Serre, Laurence, Andrieux, Annie, Fourest-Lieuvin, Anne, Blanchoin, Laurent, Arnal, Isabelle · 2015 · Scientific Reports
  54. Energy Inhibition Elevates β-Secretase Levels and Activity and Is Potentially Amyloidogenic in APP Transgenic Mice: Possible Early Events in Alzheimer's Disease Pathogenesis
    Velliquette, Rodney A., O'Connor, Tracy, Vassar, Robert · 2005 · The Journal of Neuroscience
  55. Nanotechnology—novel therapeutics for CNS disorders
    Srikanth, Maya, Kessler, John A. · 2012 · Nature Reviews Neurology
  56. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer’s disease
    Stutzbach, Lauren D, Xie, Sharon X, Naj, Adam C, Albin, Roger, Gilman, Sid, PSP Genetics Study Group, Lee, Virginia M Y, Trojanowski, John Q, Devlin, Bernie, Schellenberg, Gerard D · 2013 · Acta Neuropathologica Communications
  57. Living Neurons with Tau Filaments Aberrantly Expose Phosphatidylserine and Are Phagocytosed by Microglia
    Brelstaff, Jack, Tolkovsky, Aviva M., Ghetti, Bernardino, Goedert, Michel, Spillantini, Maria Grazia · 2018 · Cell Reports
  58. The role of microglial P2X7: modulation of cell death and cytokine release
    He, Yingbo, Taylor, Natalie, Fourgeaud, Lawrence, Bhattacharya, Anindya · 2017 · Journal of Neuroinflammation
  59. Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans
    Owen, David R, Narayan, Nehal, Wells, Lisa, Healy, Luke, Smyth, Erica, Rabiner, Eugenii A, Galloway, Dylan, Williams, John B, Lehr, Joshua, Mandhair, Harpreet et al. · 2017 · Journal of Cerebral Blood Flow &amp; Metabolism
  60. Caspase-2 cleavage of tau reversibly impairs memory
    Zhao, Xiaohui, Kotilinek, Linda A, Smith, Benjamin, Hlynialuk, Chris, Zahs, Kathleen, Ramsden, Martin, Cleary, James, Ashe, Karen H · 2016 · Nature Medicine
  61. Tau-Centric targets and drugs in clinical development for the treatment of alzheimer's disease
    Panza, Francesco, Solfrizzi, Vincenzo, Seripa, Davide, Imbimbo, Bruno P., Lozupone, Madia, Santamato, Andrea, Zecca, Chiara, Barulli, Maria Rosaria, Bellomo, Antonello, Pilotto, Alberto et al. · 2016 · BioMed Research International
  62. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood–Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease
    Deo, Anand K., Borson, Soo, Link, Jeanne M., Domino, Karen, Eary, Janet F., Ke, Ban, Richards, Todd L., Mankoff, David A., Minoshima, Satoshi, O’Sullivan, Finbarr et al. · 2014 · Journal of Nuclear Medicine
  63. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
    Rodriguez, Gustavo A, Tai, Leon M, LaDu, Mary Jo, Rebeck, G William · 2014 · Journal of Neuroinflammation
  64. Effects of Microglia on Neurogenesis
    Sato, Kaoru · 2015 · Glia
  65. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease
    Chin, Jeannie, Massaro, Catherine M., Palop, Jorge J., Thwin, Myo T., Yu, Gui-Qiu, Bien-Ly, Nga, Bender, Aaron, Mucke, Lennart · 2007 · The Journal of Neuroscience
  66. TREM2 dependent and independent functions of microglia in Alzheimer’s disease
    Hou, Jinchao, Chen, Yun, Grajales-Reyes, Gary, Colonna, Marco · 2022 · Molecular Neurodegeneration
  67. TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance
    Xiang, Xianyuan, Werner, Georg, Bohrmann, Bernd, Liesz, Arthur, Mazaheri, Fargol, Capell, Anja, Feederle, Regina, Knuesel, Irene, Kleinberger, Gernot, Haass, Christian · 2016 · EMBO Molecular Medicine
  68. Three Dimensional Human Neuro-Spheroid Model of Alzheimer’s Disease Based on Differentiated Induced Pluripotent Stem Cells
    Lee, Han-Kyu, Velazquez Sanchez, Clara, Chen, Mei, Morin, Peter J., Wells, John M., Hanlon, Eugene B., Xia, Weiming · 2016 · PLOS ONE
  69. Pathological tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis
    Meier, Shelby, Bell, Michelle, Lyons, Danielle N., Rodriguez-Rivera, Jennifer, Ingram, Alexandria, Fontaine, Sarah N., Mechas, Elizabeth, Chen, Jing, Wolozin, Benjamin, LeVine, Harry et al. · 2016 · The Journal of Neuroscience
  70. First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease
    Ferrero, James, Williams, Leslie, Stella, Heather, Leitermann, Kate, Mikulskis, Alvydas, O'Gorman, John, Sevigny, Jeff · 2016 · Alzheimer's &amp; Dementia: Translational Research &amp; Clinical Interventions
  71. The role of myelin damage in Alzheimer’s disease pathology
    Papuć, Ewa, Rejdak, Konrad · 2020 · Archives of Medical Science
  72. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72
    Mann, David MA, Rollinson, Sara, Robinson, Andrew, Bennion Callister, Janis, Thompson, Jennifer C, Snowden, Julie S, Gendron, Tania, Petrucelli, Leonard, Masuda-Suzukake, Masami, Hasegawa, Masato et al. · 2013 · Acta Neuropathologica Communications
  73. Role of Adiposity-Driven Inflammation in Depressive Morbidity
    Capuron, Lucile, Lasselin, Julie, Castanon, Nathalie · 2017 · Neuropsychopharmacology
  74. Anti‐tau antibody reduces insoluble tau and decreases brain atrophy
    Yanamandra, Kiran, Jiang, Hong, Mahan, Thomas E., Maloney, Susan E., Wozniak, David F., Diamond, Marc I., Holtzman, David M. · 2015 · Annals of Clinical and Translational Neurology
  75. Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples
    Gillespie, Anna K., Jones, Emily A., Lin, Yuan-Hung, Karlsson, Mattias P., Kay, Kenneth, Yoon, Seo Yeon, Tong, Leslie M., Nova, Philip, Carr, Jessie S., Frank, Loren M. et al. · 2016 · Neuron
  76. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
    Dupont, Anne-Claire, Largeau, Bérenger, Santiago Ribeiro, Maria, Guilloteau, Denis, Tronel, Claire, Arlicot, Nicolas · 2017 · International Journal of Molecular Sciences
  77. Heterogeneity in Alzheimer’s Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials
    Duara, Ranjan, Barker, Warren · 2022 · Neurotherapeutics
  78. Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model
    Nisbet, Rebecca M., Van der Jeugd, Ann, Leinenga, Gerhard, Evans, Harrison T., Janowicz, Phillip W., Götz, Jürgen · 2017 · Brain
  79. Increased 4R-Tau Induces Pathological Changes in a Human-Tau Mouse Model
    Schoch, Kathleen M., DeVos, Sarah L., Miller, Rebecca L., Chun, Seung J., Norrbom, Michaela, Wozniak, David F., Dawson, Hana N., Bennett, C. Frank, Rigo, Frank, Miller, Timothy M. · 2016 · Neuron
  80. <scp> <i>APOE</i> </scp> ε2 is associated with milder clinical and pathological <scp>A</scp> lzheimer disease
    Serrano‐Pozo, Alberto, Qian, Jing, Monsell, Sarah E., Betensky, Rebecca A., Hyman, Bradley T. · 2015 · Annals of Neurology
  81. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
    Öhrfelt, Annika, Brinkmalm, Ann, Dumurgier, Julien, Brinkmalm, Gunnar, Hansson, Oskar, Zetterberg, Henrik, Bouaziz-Amar, Elodie, Hugon, Jacques, Paquet, Claire, Blennow, Kaj · 2016 · Alzheimer's Research &amp; Therapy
  82. Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
    Dionisio-Santos, Dawling A., Olschowka, John A., O’Banion, M. Kerry · 2019 · Journal of Neuroinflammation
  83. Frontotemporal lobar degeneration
    Grossman, Murray, Seeley, William W., Boxer, Adam L., Hillis, Argye E., Knopman, David S., Ljubenov, Peter A., Miller, Bruce, Piguet, Olivier, Rademakers, Rosa, Whitwell, Jennifer L. et al. · 2023 · Nature Reviews Disease Primers
  84. Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
    Nalivaeva, Natalia N., Turner, Anthony J., Zhuravin, Igor A. · 2018 · Frontiers in Neuroscience
  85. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation
    Buttini, Manuel, Yu, Gui-Qiu, Shockley, Kristina, Huang, Yadong, Jones, Brian, Masliah, Eliezer, Mallory, Margaret, Yeo, Tracy, Longo, Frank M., Mucke, Lennart · 2002 · The Journal of Neuroscience
  86. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology
    Nuriel, Tal, Angulo, Sergio L., Khan, Usman, Ashok, Archana, Chen, Qiuying, Figueroa, Helen Y., Emrani, Sheina, Liu, Li, Herman, Mathieu, Barrett, Geoffrey et al. · 2017 · Nature Communications
  87. Using the Alzheimer’s Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer’s disease
    Veitch, Dallas P., Weiner, Michael W., Aisen, Paul S., Beckett, Laurel A., DeCarli, Charles, Green, Robert C., Harvey, Danielle, Jack, Clifford R., Jagust, William, Landau, Susan M. et al. · 2022 · Alzheimer's &amp; Dementia
  88. TREM2 in CNS homeostasis and neurodegenerative disease
    Painter, Meghan M., Atagi, Yuka, Liu, Chia-Chen, Rademakers, Rosa, Xu, Huaxi, Fryer, John D., Bu, Guojun · 2015 · Molecular Neurodegeneration
  89. Fluid Biomarkers for Synaptic Dysfunction and Loss
    Camporesi, Elena, Nilsson, Johanna, Brinkmalm, Ann, Becker, Bruno, Ashton, Nicholas J, Blennow, Kaj, Zetterberg, Henrik · 2020 · Biomarker Insights
  90. Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
    Vercruysse, Pauline, Vieau, Didier, Blum, David, Petersén, Åsa, Dupuis, Luc · 2018 · Frontiers in Molecular Neuroscience
  91. Combination Therapy in Alzheimer???s Disease: A Review of Current Evidence
    Schmitt, Beate, Bernhardt, Tanja, Moeller, Hans-Juergen, Heuser, Isabella, Fr??lich, Lutz · 2004 · CNS Drugs
  92. Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration
    Ding, Xin, Wang, Jin, Huang, Miaoxin, Chen, Zhangpeng, Liu, Jing, Zhang, Qipeng, Zhang, Chenyu, Xiang, Yang, Zen, Ke, Li, Liang · 2021 · Nature Communications
  93. Tau isoform regulation is region‐ and cell‐specific in mouse brain
    McMillan, Pamela, Korvatska, Elena, Poorkaj, Parvoneh, Evstafjeva, Zana, Robinson, Linda, Greenup, Lynne, Leverenz, James, Schellenberg, Gerard D., D'Souza, Ian · 2008 · Journal of Comparative Neurology
  94. Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
    Izzo, Nicholas J., Staniszewski, Agnes, To, Lillian, Fa, Mauro, Teich, Andrew F., Saeed, Faisal, Wostein, Harrison, Walko, Thomas, Vaswani, Anisha, Wardius, Meghan et al. · 2014 · PLoS ONE
  95. Rapid Tyrosine Phosphorylation of Neuronal Proteins Including Tau and Focal Adhesion Kinase in Response to Amyloid-β Peptide Exposure: Involvement of Src Family Protein Kinases
    Williamson, Ritchie, Scales, Timothy, Clark, Bruce R., Gibb, Graham, Reynolds, C. Hugh, Kellie, Stuart, Bird, Ian N., Varndell, Ian M., Sheppard, Paul W., Everall, Ian et al. · 2002 · The Journal of Neuroscience
  96. Cerebrospinal fluid neurogranin and <scp>YKL</scp> ‐40 as biomarkers of Alzheimer's disease
    Janelidze, Shorena, Hertze, Joakim, Zetterberg, Henrik, Landqvist Waldö, Maria, Santillo, Alexander, Blennow, Kaj, Hansson, Oskar · 2016 · Annals of Clinical and Translational Neurology
  97. Impaired default network functional connectivity in autosomal dominant Alzheimer disease
    Chhatwal, Jasmeer P., Schultz, Aaron P., Johnson, Keith, Benzinger, Tammie L.S., Jack, Clifford, Ances, Beau M., Sullivan, Caroline A., Salloway, Stephen P., Ringman, John M., Koeppe, Robert A. et al. · 2013 · Neurology
  98. Adult neurogenesis and neurodegenerative diseases: A systems biology perspective
    Horgusluoglu, Emrin, Nudelman, Kelly, Nho, Kwangsik, Saykin, Andrew J. · 2017 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
  99. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
    Liao, Fan, Li, Aimin, Xiong, Monica, Bien-Ly, Nga, Jiang, Hong, Zhang, Yin, Finn, Mary Beth, Hoyle, Rosa, Keyser, Jennifer, Lefton, Katheryn B. et al. · 2018 · Journal of Clinical Investigation
  100. Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
    Brookmeyer, Ron, Abdalla, Nada · 2018 · Alzheimer's &amp; Dementia